Diab A, Gogas H, Sandhu S, Long GV, et al. Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. J Clin Oncol 2023 Aug 31:JCO2300172. doi: 10.1200/JCO.23.00172.
PMID: 37651676